SCM
VXRT

Stonepine Capital Management’s Vaxart VXRT Stock Holding History

Stonepine Capital Management’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-28,584
Closed -$205K – 29
2017
Q1 		$205K Buy
28,584
+468
+2% +$4.79K 0.12% 21
2016
Q4 		$380K Sell
28,116
-3,469
-11% -$53K 0.23% 23
2016
Q3 		$667K Buy
31,585
+4,833
+18% +$76.4K 0.54% 15
2016
Q2 		$412K Buy
+26,752
New +$445K 0.42% 22

Other funds holding VXRT

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
TL
TowerView LLC New York $155M AUM 30.14% 1-Year Est. Return

Stonepine Capital Management's VXRT Position: Q2 2017 in Review

Stonepine Capital Management sold out of Vaxart (VXRT) in Q2 2017, closing a stake of 28,584 shares — an estimated $205K sold.

Stonepine Capital Management first reported a position in VXRT in Q2 2016 and held it in 4 quarters. The position peaked at $667K in Q3 2016. 32 funds tracked by Wall St. Rank hold VXRT as of Q2 2017.

  • Stonepine Capital Management reported no remaining Vaxart position as of Q2 2017 after selling out during the quarter.
  • Stonepine Capital Management sold 28,584 Vaxart shares in Q2 2017, an estimated $205K.
  • Stonepine Capital Management first reported a position in Vaxart in Q2 2016 and held it in 4 quarters.
  • Stonepine Capital Management's Vaxart position peaked at $667K in Q3 2016.
  • 32 funds tracked by Wall St. Rank held Vaxart as of Q2 2017.

Based on Stonepine Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.